Food and Drug Administration for any human or veterinary indication
N-Acetylcysteine (NAC) Directly supplies cysteine, essential for glutathione synthesis
Most commercially available supplements in the UK provide doses ranging from 500 mg to 2,000 mg per day, typically taken in one or two divided doses
Protein shakes designed for GLP-1 users and specific recipes can help patients meet their nutritional needs while navigating reduced appetite
There are oral tablets or capsules, sublingual applications (under the tongue), intramuscular injections, and skin patches, among others
Phase 2 trial results by dose (48 weeks) Phase 3 TRIUMPH-4 results (68 weeks) The phase 3 TRIUMPH-4 data, released in early 2026, confirmed and exceeded the phase 2 results